Menu

IGC Pharma, Inc. IGC

Full chart Compare
Set alert

Price alert · IGC

All alert types
0.19 USD -0.01 (-3.08%)

At closeNov 6, 2026, 4:35 AM EST

0.19 0.00 0.00%

Pre-market · Nov 6, 4:35 AM ET

0.184 Day range 0.1973
0.08 52-week range 0.40
YTD
-32.50%
1 year
-51.54%

Revenue & Expenses

Other Income → Expenses: $3.65MExpenses → Selling, General & Admin: $5.36MExpenses → Research & Development: $5.19MGross Profit → Expenses: $352.00KRevenue → Gross Profit: $352.00KRevenue → Cost of Revenue: $834.00KNet Loss → Expenses: $6.55MOther Income$3.65MGross Profit$352.00KNet Loss$6.55MCost of Revenue$834.00KExpenses$10.55MSelling, General & Admin$5.36MResearch & Development$5.19MRevenue$1.19M

Latest period ending Mar 31, 2025 · select a line to chart its full history

Annual income statement

IGC annual income statement
Fiscal yearFY 2025 Mar 31, 2025FY 2024 Mar 31, 2024FY 2023 Mar 31, 2023FY 2022 Mar 31, 2022FY 2021 Mar 31, 2021
1.27M1.34M911.00K397.00K898.00K
1.27M1.34M911.00K397.00K898.00K
652.00K612.00K469.00K203.00K785.00K
619.00K733.00K442.00K194.00K113.00K
8.06M10.53M12.01M15.62M8.84M
3.65M3.77M3.46M2.33M929.00K
4.41M6.76M8.55M13.29M7.91M
-7.45M-9.80M-11.57M-15.43M-8.72M
-7.12M-13.00M-11.51M-15.02M-8.81M
-7.12M-13.00M-11.51M-15.02M-8.81M
-7.12M-13.00M-11.51M-15.02M-8.81M
-7.12M-13.00M-11.51M-15.02M-8.81M
-0.09-0.22-0.22-0.30-0.21
-0.09-0.22-0.22-0.30-0.21
-0.09-0.22-0.22-0.30-0.21
-7.12M-13.00M-11.51M-15.02M-8.81M
-7.12M-13.00M-11.51M-15.02M-8.81M
76.52M58.84M52.58M49.99M41.96M
76.52M58.84M52.58M49.99M41.96M